PMM2
Phosphomannomutase 2 is an enzyme that in humans is encoded by the PMM2 gene.[1][2]
Phosphomannomutase 2 catalyzes the isomerization of mannose 6-phosphate to mannose 1-phosphate. Mannose 1-phosphate is a precursor to GDP-mannose necessary for the synthesis of dolichol-P-oligosaccharides. Mutations in the gene have been shown to cause defects in the protein glycosylation pathway manifest as carbohydrate-deficient glycoprotein syndrome type I.[2]
This enzyme has been found in the venom of social wasp species Polistes major major. [3]
References
- ↑ Matthijs G, Schollen E, Pardon E, Veiga-Da-Cunha M, Jaeken J, Cassiman JJ, Van Schaftingen E (Jun 1997). "Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome)". Nat Genet 16 (1): 88–92. doi:10.1038/ng0597-88. PMID 9140401.
- 1 2 "Entrez Gene: PMM2 phosphomannomutase 2".
- ↑ Identification of three novel peptides isolated from the venom of the neotropical social wasp Polistes major major/Vaclav Cerovsky/Jan Pohl/Zhihua Yang/Naseer Alam/Athula B. Attygalle
Further reading
- Matthijs G, Schollen E, Heykants L, Grünewald S (2000). "Phosphomannomutase deficiency: the molecular basis of the classical Jaeken syndrome (CDGS type Ia)". Mol. Genet. Metab. 68 (2): 220–6. doi:10.1006/mgme.1999.2914. PMID 10527672.
- Jaeken J, Matthijs G (2002). "Congenital disorders of glycosylation". Annual review of genomics and human genetics 2: 129–51. doi:10.1146/annurev.genom.2.1.129. PMID 11701646.
- Martinsson T, Bjursell C, Stibler H, et al. (1995). "Linkage of a locus for carbohydrate-deficient glycoprotein syndrome type I (CDG1) to chromosome 16p, and linkage disequilibrium to microsatellite marker D16S406". Hum. Mol. Genet. 3 (11): 2037–42. PMID 7874123.
- Matthijs G, Schollen E, Pirard M, et al. (1997). "PMM (PMM1), the human homologue of SEC53 or yeast phosphomannomutase, is localized on chromosome 22q13". Genomics 40 (1): 41–7. doi:10.1006/geno.1996.4536. PMID 9070917.
- Schollen E, Pardon E, Heykants L, et al. (1998). "Comparative analysis of the phosphomannomutase genes PMM1, PMM2 and PMM2psi: the sequence variation in the processed pseudogene is a reflection of the mutations found in the functional gene". Hum. Mol. Genet. 7 (2): 157–64. doi:10.1093/hmg/7.2.157. PMID 9425221.
- Matthijs G, Schollen E, Van Schaftingen E, et al. (1998). "Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A". Am. J. Hum. Genet. 62 (3): 542–50. doi:10.1086/301763. PMC 1376957. PMID 9497260.
- Kjaergaard S, Skovby F, Schwartz M (1998). "Absence of homozygosity for predominant mutations in PMM2 in Danish patients with carbohydrate-deficient glycoprotein syndrome type 1". Eur. J. Hum. Genet. 6 (4): 331–6. doi:10.1038/sj.ejhg.5200194. PMID 9781039.
- Bjursell C, Wahlström J, Berg K, et al. (1999). "Detailed mapping of the phosphomannomutase 2 (PMM2) gene and mutation detection enable improved analysis for Scandinavian CDG type I families". Eur. J. Hum. Genet. 6 (6): 603–11. doi:10.1038/sj.ejhg.5200234. PMID 9887379.
- Kondo I, Mizugishi K, Yoneda Y, et al. (1999). "Missense mutations in phosphomannomutase 2 gene in two Japanese families with carbohydrate-deficient glycoprotein syndrome type 1". Clin. Genet. 55 (1): 50–4. doi:10.1034/j.1399-0004.1999.550109.x. PMID 10066032.
- Vuillaumier-Barrot S, Barnier A, Cuer M, et al. (1999). "Characterization of the 415G>A (E139K) PMM2 mutation in carbohydrate-deficient glycoprotein syndrome type Ia disrupting a splicing enhancer resulting in exon 5 skipping". Hum. Mutat. 14 (6): 543–4. doi:10.1002/(SICI)1098-1004(199912)14:6<543::AID-HUMU17>3.0.CO;2-S. PMID 10571956. replacement character in
|first4=at position 7 (help) - Kjaergaard S, Skovby F, Schwartz M (2000). "Carbohydrate-deficient glycoprotein syndrome type 1A: expression and characterisation of wild type and mutant PMM2 in E. coli". Eur. J. Hum. Genet. 7 (8): 884–8. doi:10.1038/sj.ejhg.5200398. PMID 10602363.
- Imtiaz F, Worthington V, Champion M, et al. (2000). "Genotypes and phenotypes of patients in the UK with carbohydrate-deficient glycoprotein syndrome type 1". J. Inherit. Metab. Dis. 23 (2): 162–74. doi:10.1023/A:1005669900330. PMID 10801058.
- Vuillaumier-Barrot S, Hetet G, Barnier A, et al. (2000). "Identification of four novel PMM2 mutations in congenital disorders of glycosylation (CDG) Ia French patients". J. Med. Genet. 37 (8): 579–80. doi:10.1136/jmg.37.8.579. PMC 1734666. PMID 10922383.
- Matthijs G, Schollen E, Bjursell C, et al. (2000). "Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia)". Hum. Mutat. 16 (5): 386–94. doi:10.1002/1098-1004(200011)16:5<386::AID-HUMU2>3.0.CO;2-Y. PMID 11058895.
- Bjursell C, Erlandson A, Nordling M, et al. (2000). "PMM2 mutation spectrum, including 10 novel mutations, in a large CDG type 1A family material with a focus on Scandinavian families". Hum. Mutat. 16 (5): 395–400. doi:10.1002/1098-1004(200011)16:5<395::AID-HUMU3>3.0.CO;2-T. PMID 11058896. replacement character in
|last5=at position 8 (help) - Westphal V, Enns GM, McCracken MF, Freeze HH (2001). "Functional analysis of novel mutations in a congenital disorder of glycosylation Ia patient with mixed Asian ancestry". Mol. Genet. Metab. 73 (1): 71–6. doi:10.1006/mgme.2001.3174. PMID 11350185.
- Heykants L, Schollen E, Grünewald S, Matthijs G (2001). "Identification and localization of two mouse phosphomannomutase genes, Pmm1 and Pmm2". Gene 270 (1–2): 53–9. doi:10.1016/S0378-1119(01)00481-4. PMID 11404002.
| |||||||||
External links
- GeneReviews/NCBI/NIH/UW entry on Congenital Disorders of Glycosylation Overview
- GeneReviews/NIH/NCBI/UW entry on PMM2-CDG (CDG-Ia)Carbohydrate-Deficient Glycoprotein Syndrome, Type 1a; Congenital Disorder of Glycosylation Type 1a; Jaeken Syndrome
- OMIM entries on Carbohydrate-Deficient Glycoprotein Syndrome, Type 1a; Congenital Disorder of Glycosylation Type 1a; Jaeken Syndrome
| ||||||||||||||
This article is issued from Wikipedia - version of the Monday, July 27, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.